![Charmaine Gittleson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charmaine Gittleson
Ordförande på
PERCHERON THERAPEUTICS LIMITED
Förmögenhet: 5 199 $ per 2026-07-31
Profil
Charmaine Gittleson is Non-Executive Chairman at Percheron Therapeutics Ltd. since 2023, Independent Non-Executive Director at Polynovo Ltd. starting 2026, Non-Executive Director at George Medicines Pty Ltd., and Non-Executive Director at Imugene Ltd. starting 2026.
Former roles include Chairman at Patrys Ltd. from 2022 to 2025 and Chief Medical Officer at CSL Ltd. Education includes an undergraduate degree from the University of the Witwatersrand.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2024-12-31 | 2 464 000 ( 0,16 % ) | 5 199 $ | 2026-07-31 |
Aktiva positioner av Charmaine Gittleson
| Företag | Position | Start |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Ordförande | - |
| POLYNOVO LIMITED | Direktör/Styrelseledamot | 2026-04-01 |
| IMUGENE LIMITED | Direktör/Styrelseledamot | 2026-06-30 |
Tidigare kända positioner av Charmaine Gittleson
| Företag | Position | Slut |
|---|---|---|
| PATRYS LIMITED | Ordförande | 2025-06-17 |
| CSL LIMITED | Teknisk/Vetenskaplig/F&U Direktör | - |
Charmaine Gittlesons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
51
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Polynovo Ltd.
 Polynovo Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
